Proton Magnetic Resonance Spectroscopic Imaging of Human Breast Cancer: A Preliminary Study

Journal of Magnetic Resonance Imaging

Volumn 19, Issue 1, 2004, Pages 68-75

  Jacobs, Michael A ^a   Barker, Peter B ^a,b   Bottomley, Paul A ^a   Bhujwalla, Zaver ^a   Bluemke, David A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Breast; Cancer; Magnetic resonance; Radiologic pathological correlation; Spectroscopic imaging; Spectroscopy

Indexed keywords

CHOLINE; LIPID; WATER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER INFILTRATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; IMAGING SYSTEM; MEASUREMENT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; SIGNAL NOISE RATIO; TISSUE LEVEL; TISSUE SLICE;

ADULT; AGED; BREAST NEOPLASMS; CHOLINE; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; PROTONS;

EID: 0346829863     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10427     Document Type: Article

References (40)

1. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220:13-30.
2. Aboagye EO, Bhujwalla ZM. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 1999;59:80-84.
3. Degani H, Furman E, Fields S. Magnetic resonance imaging and spectroscopy of MCF7 human breast cancer: pathophysiology and monitoring of treatment. Clin Chim Acta 1994;228:19-33.
4. Gribbestad IS, Petersen SB, Fjosne HE, Kvinnsland S, Krane J. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed 1994;7:181-194.
5. Yeung DK, Cheung HS, Tse GM. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy-initial results. Radiology 2001;220:40-46.
6. Thomas MA, Binesh N, Yue K, DeBruhl N. Volume-localized two-dimensional correlated magnetic resonance spectroscopy of human breast cancer. J Magn Reson Imaging 2001;14:181-186.
7. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001;68:45-54.
8. Gribbestad IS, Sitter B, Lundgren S, Krane J, Axelson D. Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res 1999;19:1737-1746.
9. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998;209:269-275.
10. Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging 1999;10:159-164.
11. Haase A, Frahm J, Hanicke W, Matthaei D. H-1-Nmr chemical-shift selective (Chess) imaging. Phys Med Biol 1985;30:341-344.
12. Jacobs MA, Knight RA, Windham JP, et al. Identification of cerebral ischemic lesions in rat using eigenimage filtered magnetic resonance imaging. Brain Res 1999;837:83-94.
13. Windham JP, Abd-Allah MA, Reimann DA, Froelich JW, Haggar AM. Eigenimage filtering in MR imaging. J Comput Assist Tomogr 1988;12:1-9.
14. Jacobs MA, Knight RA, Soltanian-Zadeth H, et al. Unsupervised segmentation of multiparameter MRI in experimental cerebral ischemia with comparison to T2, diffusion, and ADC MRI parameters and histopathological validation. J Magn Reson Imaging 2000;11:425-437.
15. Jagannathan NR, Singh M, Govindaraju V, et al. Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy. NMR Biomed 1998;11:414-422.
16. Gribbestad IS, Singstad TE, Nilsen G, et al. In vivo H-1 MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 1998;8:1191-1197.
17. Katz-Brull R, Lavin PT, Lenkinski RE. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002;94:1197-1203.
18. Gill SS, Thomas DG, Van Bruggen N, et al. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J Comput Assist Tomogr 1990;14:497-504.
19. Kurhanewicz J, Vigneron DB, Nelson SJ, et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 1995;45:459-466.
20. Mukherji SK, Schiro S, Castillo M, Kwock L, Muller KE, Blackstock W. Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. AJNR Am J Neuroradiol 1997;18:1057-1072.
21. Lawrence WF, Liang W, Mandelblatt JS, et al. Serendipity in diagnostic imaging: magnetic resonance imaging of the breast. J Natl Cancer Inst 1998;90:1792-1800.
22. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993;188:277-282.
23. Husted CA, Duijn JH, Matson GB, Maudsley AA, Weiner MW. Molar quantitation of in vivo proton metabolites in human brain with 3D magnetic resonance spectroscopic imaging. Magn Reson Imaging 1994;12:661-667.
24. Posse S, DeCarli C, Le Bihan D. Three-dimensional echo-planar MR spectroscopic imaging at short echo times in the human brain. Radiology 1994;192:733-738.
25. Duyn JH, Frank JA, Moonen CT. Incorporation of lactate measurement in multi-spin-echo proton spectroscopic imaging. Magn Reson Med 1995;33:101-107.
26. Dydak U, Weiger M, Pruessmann KP, Meier D, Boesiger P. Sensitivity-encoded spectroscopic imaging. Magn Reson Med 2001;46:713-722.
27. Bolan PJ, DelaBarre L, Baker EH, et al. Eliminating spurious lipid sidebands in 1H MRS of breast lesions. Magn Reson Med 2002;48:215-222.
28. Pan JW, Twieg DB, Hetherington HP. Quantitative spectroscopic imaging of the human brain. Magn Reson Med 1998;40:363-369.
29. Michaelis T, Merboldt KD, Bruhn H, Hanicke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993;187:219-227.
30. Barker PB, Soher BJ, Blackband SJ, Chatham JC, Mathews VP, Bryan RN. Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference. NMR Biomed 1993;6:89-94.
31. Alger JR, Symko SC, Bizzi A, Posse S, DesPres DJ, Armstrong MR. Absolute quantitation of short TE brain 1H-MR spectra and spectroscopic imaging data. J Comput Assist Tomogr 1993;17:191-199.
32. Kreis R, Ernst T, Ross B. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson B 1993;102:9-19.
33. Bakken IJ, Gribbestad IS, Singstad TE, Kvistad KA. External standard method for the in vivo quantification of choline-containing compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla. Magn Reson Med 2001;46:189-192.
34. Soher BJ, Hurd RE, Sailasuta N, Barker PB. Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference. Magn Reson Med 1996;36:335-339.
35. Smith JK, Kwock L, Castillo M. Effects of contrast material on single-volume proton MR spectroscopy. AJNR Am J Neuroradiol 2000;21:1084-1089.
36. Sijens PE, Oudkerk M, van Dijk P, Levendag PC, Vecht CJ. 1H MR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration. Magn Reson Imaging 1998;16:1273-1280.
37. Akbudak E, Norberg RE, Conturo TE. Contrast-agent phase effects: an experimental system for analysis of susceptibility, concentration, and bolus input function kinetics. Magn Reson Med 1997;38:990-1002.
38. Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal human breast tissues with in vivo H-1 MR spectroscopy. J Magn Reson Imaging 1999;10:159-164.
39. Jagannathan NR, Kumar M, Seenu V, et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001;84:1016-1022.
40. Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DB. Proton MR spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 2004;19:68-75.